Boulder, Colorado, July 03, 2018 (GLOBE NEWSWIRE) -- REACH Genetics, Inc., announced on Tuesday, July 3, 2018, that they have entered into a Joint Venture Agreement that was finalized as of the 25th day of June, 2018, by and between REACH Genetics, Inc., a Nevada Corporation, and Ohana Agricultural Resources, LLC, a Domestic Limited Liability Company registered in Hawaii, and Jaroma, LLC, a Domestic Limited Liability Company registered in Hawaii. The joint venture formed pursuant to this Agreement will do business under the name Hiwahiwa Ola, Inc.™, and shall have its legal address at 54-058 Hauula Homestead Rd, Hauula, HI 96717. Hiwahiwa Ola means Precious Life.
Hawaii’s Hiwahiwa Ola™ brings healing power to the “Body, Mind and Spirit”. When brought into balance only then can Hawaiian land and culture evolve and transform. Hawaii’s Hiwahiwa Ola™ produces essential wholistic Premium Rich Hemp and Natural Hawaiian extract oils and their byproducts to serve Hawaii and our people.
We are currently working to release our Premium Whole Plant Hemp Extract which will be sold as MOANI™ (Gentle Breeze) Extracts. Moani™ Extracts are bringing relief to lives using the whole plant hemp extract and 0% THC (the psychoactive component of the plant).
Moani’s tinctures are all natural, safe and effective rich whole plant premium CBD oils formulated for maximum absorption. Every extraction batch is lab tested for purity, safety and of course, the products contain ZERO THC. This places our strains amongst the purest available Worldwide making them the best choice for those looking for relief without the risk of encountering a psychoactive entourage effect.
Tinctures are quickly becoming one of the most popular ways to consume CBD. And Moani’s tinctures are made with a proprietary blend of coconut MCT oil and organic flavorings to accelerate absorption providing a super refreshing taste.
Hiwahiwa Ola, Inc.™ has successfully partnered with various hemp businesses in the food and construction verticals. We've created a platform that contributes back to the Native Hawaiian communities and have established an international network of hemp-based relationships.
About REACH Genetics, Inc.
Launched in October 2015, REACH Genetics, Inc. a US company, began as a consultancy firm and has evolved to include an international research and development partnership for Industrial Hemp. Its leadership team merges traditional business management with an outsourced team of scientists that focus on data collection and analysis of chemical, genetic and phenotypic profiles of hemp, allowing the company to create proprietary varieties of hemp that are targeted for specific uses for the emerging markets.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
Forward Looking Statements:
This communication shall not constitute an offer to sell or the solicitation of an offer to buy securities nor shall there be any sale of these securities in any state in which such solicitation or sale would be unlawful prior to registration or qualification of these securities under the laws of any such state.
This Press Release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These “forward-looking statements” that address activities, events or developments that Doyen Elements, Inc. expects, anticipates, or estimates may occur in the future. Generally forward-looking statements by words such as “may,” “will,” “would,” “could,” “continue,” “potential,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “intend” and other similar expressions. There are a numerous risks and uncertainties, both known and unknown, that could cause actual results to differ materially from the results implied by the forward-looking statements, which may include but are not limited to, business risks, general industry conditions and competition, general economic factors, governmental actions, legislative conditions, the impact of cannabis industry regulation, legislation in the United States and internationally and technological advances. REACH Genetics undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.